Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Salbutamol

A beta-2 agonist bronchodilator developed in England in the 1960s and on the market since 1969: it is the medicine in the inhalers used for asthma attacks. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?In the United States it is called albuterol: the same medicine has two official names, an international one and an American one.

SalbutamolGo to the active ingredient →
SalbutamolActive ingredientSalbutamolCat. No. P-S005-001CAS 18559-94-9
Salbutamol-d3Isotopically labelledSalbutamol-d3Cat. No. P-S005-035CAS 1219798-60-3
Salbutamol-d9Isotopically labelledSalbutamol-d9Cat. No. P-S005-036CAS 1173021-73-2
ColterolImpurityColterolCat. No. P-S005-065CAS 18866-78-9

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Reference substanceSalbutamol CRSEDQM code S0100000Family Salbutamol

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.